Other OTC - Delayed Quote USD

K2X Technology & Life Science, Inc. (KBPH)

1.0000 0.0000 (0.00%)
At close: August 22 at 3:30 PM EDT
Loading Chart for KBPH
DELL
  • Previous Close 1.0000
  • Open 1.0000
  • Bid --
  • Ask --
  • Day's Range 1.0000 - 1.0000
  • 52 Week Range 1.0000 - 1.0000
  • Volume 226
  • Avg. Volume 0
  • Market Cap (intraday) 13.288M
  • Beta (5Y Monthly) 0.02
  • PE Ratio (TTM) 50.00
  • EPS (TTM) 0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

K2X Technology & Life Science, Inc. is a venture capital firm specializing in startups and early-stage companies. Its investments are either in the form of secured convertible debt paying interest and offering a discount upon conversion to preferred shares, or directly into preferred shares. The firm seeks to invest in fintech, technology and life science companies. It does not lead financing transactions. The firm makes 50% investments in the United States and the remaining in Canada, India and Israel. The company was formerly as KYTO Technology and Life Science, Inc. and changed its name to K2X Technology & Life Science, Inc. in January 2024. K2X Technology & Life Science, Inc. was founded in 1999 and is based in Los Altos Hills, California with additional offices in Scotts Valley, California and Chester, New Jersey.

k2x.capital

1

Full Time Employees

March 31

Fiscal Year Ends

Related News

Performance Overview: KBPH

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

KBPH
0.00%
S&P 500
6.33%

1-Year Return

KBPH
0.00%
S&P 500
22.70%

3-Year Return

KBPH
47.37%
S&P 500
21.33%

5-Year Return

KBPH
57.45%
S&P 500
72.88%

Compare To: KBPH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KBPH

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    -25.35k

  • Enterprise Value/EBITDA

    -11.39

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -7.19%

  • Return on Equity (ttm)

    11.75%

  • Revenue (ttm)

    -505

  • Net Income Avi to Common (ttm)

    651.61k

  • Diluted EPS (ttm)

    0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.76M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -534.33k

Company Insights: KBPH